NF-kappaB signaling pathways in neurological inflammation: A mini review

Frontiers in Molecular Neuroscience

Volumn 8, Issue DEC, 2015, Pages

  Shih, Ruey Horng ^a   Wang, Chen Yu ^b   Yang, Chuen Mao ^b  

^a NATIONAL CHENGCHI UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Adhesion molecules; Neuroinflammation; Neuroprotection; NF kappaB; Proinflammatory transcription factors

Indexed keywords

AUTACOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELA;

APOPTOSIS; BRAIN DAMAGE; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; GENETIC TRANSCRIPTION; HUMAN; IMMUNE RESPONSE; NERVOUS SYSTEM INFLAMMATION; NEUROTOXICITY; PAIN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84957807989     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2015.00077     Document Type: Review

References (98)

1. Adler, A. S., Sinha, S., Kawahara, T. L., Zhang, J. Y., Segal, E., and Chang, H. Y. (2007). Motif module map reveals enforcement of aging by continual NF-kappaB activity. Genes Dev. 21, 3244-3257. doi: 10.1101/gad.l588507
2. Aggarwal, B. B. (2004). Nuclear factor-kappaB: the enemy within. Cancer Cell 6, 203-208. doi: 10.1016/j.ccr.2004.09.003
3. Ahn, H. J., Hernandez, C. M., Levenson, J. M., Lubin, F. D., Liou, H. C., and Sweatt, J. D. (2008). C-Rel, an NF-kappaB family transcription factor, is required for hippocampal long-term synaptic plasticity and memory formation. Learn. Mem. 15, 539-549. doi: 10.1101/lm.866408
4. Ahn, K. S., and Aggarwal, B. B. (2005). Transcription factor NF-kappaB: a sensor for smoke and stress signals. Ann. N. Y. Acad. Sci. 1056, 218-233. doi: 10.1196/annals.1352.026
5. Akama, K. T., Albanese, C., Pestell, R. G., and Van Eldik, L. J. (1998). Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism. Proc. Natl Acad. Sci. U.S.A. 95, 5795-5800. doi: 10.1073/pnas.95.10.5795
6. Akira, S., and Takeda, K. (2004). Functions of toll-like receptors: lessons from KO mice. C. R. Biol. 327, 581-589. doi: 10.1016/j.crvi.2004.04.002
7. Anest, V., Hanson, J. L., Cogswell, P. C., Steinbrecher, K. A., Strahl, B. D., and Baldwin, A. S. (2003). A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. Nature 423, 659-663. doi: 10.1038/nature01648
8. Baeuerle, P. A., and Baltimore, D. (1996). NF-kappa B: ten years after. Cell 87, 13-20. doi: 10.1016/S0092-8674(00)81318-5
9. Baeuerle, P. A., and Henkel, T. (1994). Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12, 141-179. doi: 10.1146/annurev.iy.12.040194.001041
10. Baiguera, C., Alghisi, M., Pinna, A., Bellucci, A., De Luca, M. A., Frau, L., et al. (2012). Late-onset Parkinsonism in NFkappaB/c-Rel-deficient mice. Brain 135, 2750-2765. doi: 10.1093/brain/aws193
11. Bakalkin, G., Yakovleva, T., and Terenius, L. (1993). NF-kappa B-like factors in the murine brain. Developmentally-regulated and tissue-specific expression. Brain. Res. Mol. Brain Res. 20, 137-146. doi: 10.1016/0169-328X(93)90119-A
12. Baldwin, A. S. Jr. (1996). The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-683. doi: 10.1146/annurev.immunol.14.1.649
13. Barger, S. W., Horster, D., Furukawa, K., Goodman, Y., Krieglstein, J., and Mattson, M. P. (1995). Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc. Natl. Acad. Sci. U.S.A. 92, 9328-9332. doi: 10.1073/pnas.92.20.9328
14. Ben-Neriah, Y., and Karin, M. (2011).Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat. Immunol. 12, 715-723. doi: 10.1038/ni.2060
15. Bernard, D., Quatannens, B., Begue, A., Vandenbunder, B., and Abbadie, C. (2001). Antiproliferative and antiapoptotic effects of crel may occur within the same cells via the up-regulation of manganese superoxide dismutase. Cancer Res. 61, 2656-2664. doi: 10.1016/S0092-8674(00)81318-5
16. Bethea, J. R., Castro, M., Keane, R. W., Lee, T. T., Dietrich, W. D., and Yezierski, R. P. (1998). Traumatic spinal cord injury induces nuclear factor-kappaB activation. J. Neurosci. 18, 3251-3260. doi: 10.1016/S0092-8674(00)81318-5
17. Bhakar, A. L., Tannis, L. L., Zeindler, C., Russo, M. P., Jobin, C., Park, D. S., et al. (2002). Constitutive nuclear factor-kappa B activity is required for central neuron survival. J. Neurosci. 22, 8466-8475. doi: 10.1146/annurev.iy.12.040194.001041
18. Block, M. L., Zecca, L., and Hong, J. S. (2007). Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8, 57-69. doi: 10.1038/nrn2038
19. Boissiere, F., Hunot, S., Faucheux, B., Duyckaerts, C., Hauw, J. J., Agid, Y., et al. (1997). Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer's disease. Neuroreport 8, 2849-2852. doi: 10.1097/00001756199709080-00009
20. Brambilla, R., Bracchi-Ricard, V., Hu, W. H., Frydel, B., Bramwell, A., Karmally, S., et al. (2005). Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinalcord injury. J. Exp. Med. 202, 145-156. doi: 10.1084/jem.20041918
21. Chen, C., Edelstein, L. C., and Gelinas, C. (2000). The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol. Cell. Biol. 20, 2687-2695. doi: 10.1128/MCB.20.8.2687-2695.2000
22. Chen, L. F., and Greene, W. C. (2004). Shaping the nuclear action of NF-kappaB. Nat. Rev. Mol. Cell Biol. 5, 392-401. doi: 10.1038/nrm1368
23. Crack, P. J., Taylor, J. M., Ali, U., Mansell, A., and Hertzog, P. J. (2006). Potential contribution of NF-kappaB in neuronal cell death in the glutathione peroxidase-1 knockout mouse in response to ischemia-reperfusion injury. Stroke 37, 1533-1538. doi: 10.1161/01.STR.0000221708.17159.64
24. DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., and Karin, M. (1997). A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature388, 548-554. doi: 10.1038/41493
25. Duh, E. J., Maury, W. J., Folks, T. M., Fauci, A. S., and Rabson, A. B.(1989). Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc. Natl. Acad. Sci. U.S.A. 86, 5974-5978. doi: 10.1073/pnas.86.15.5974
26. El-Hage, N., Bruce-Keller, A. J., Yakovleva, T., Bazov, I., Bakalkin, G., Knapp, P. E., et al. (2008). Morphine exacerbates HIV-1. Tat-induced cytokine production in astrocytes through convergent effects on [Ca(2+)](i), NF-kappaB trafficking and transcription. PLoS ONE 3, e4093. doi: 10.1371/journal.pone.0004093
27. Farina, C., Aloisi, F., and Meinl, E. (2007). Astrocytes are active players in cerebral innate immunity. Trends Immunol. 28, 138-145. doi: 10.1016/j.it.2007.01.005
28. Finco, T. S., and Baldwin, A. S. (1995). Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis. Immunity 3, 263-272. doi: 10.1016/1074-7613(95)90112-4
29. Ghosh, A., Roy, A., Liu, X., Kordower, J. H., Mufson, E. J., Hartley, D. M., et al. (2007). Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 104, 18754-18759. doi: 10.1073/pnas.0704908104
30. Gray, C. M., Remouchamps, C., Mccorkell, K. A., Solt, L. A., Dejardin, E., Orange, J. S., et al. (2014). Noncanonical NF-kappaB signaling is limited by classical NF-kappaB activity. Sci. Signal. 7, ra13. doi: 10.1126/scisignal.2004557
31. Gupta, S. C., Kim, J. H., Prasad, S., and Aggarwal, B. B. (2010a). Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev29, 405-434. doi: 10.1007/s10555-010-9235-2
32. Gupta, S. C., Sundaram, C., Reuter, S., and Aggarwal, B. B. (2010b). Inhibiting NF-kappaB activation by small molecules as a therapeutic strategy. Biochim. Biophys. Acta 1799, 775-787. doi: 10.1016/j.bbagrm.2010.05.004
33. Hoshino, K., Sugiyama, T., Matsumoto, M., Tanaka, T., Saito, M., Hemmi, H., et al. (2006). IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Nature 440, 949-953. doi: 10.1038/nature04641
34. Hunot, S., Brugg, B., Ricard, D., Michel, P. P., Muriel, M. P., Ruberg, M., et al. (1997). Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. Proc. Natl. Acad. Sci. U.S.A. 94, 7531-7536. doi: 10.1073/pnas.94.14.7531
35. Ingrassia, R., Lanzillotta, A., Sarnico, I., Benarese, M., Blasi, F., Borgese, L., et al. (2012). 1B/(-)IRE DMT1 expression during brain ischemia contributes to cell death mediated byNF-kappaB/RelA acetylation at Lys310. PLoS ONE 7,e38019.doi: 10.1371/journal.pone.0038019
36. Inta, I., Paxian, S., Maegele, I., Zhang, W., Pizzi, M., Spano, P., et al. (2006). Bim and Noxa are candidates to mediate the deleterious effect of the NF-kappa B subunit RelA in cerebral ischemia. J. Neurosci. 26, 12896-12903. doi: 10.1523/JNEUROSCI.3670-06.2006
37. Kaltschmidt, B., and Kaltschmidt, C. (2009). NF-kappaB in the nervous system. Cold Spring Harb. Perspect. Biol. 1, a001271. doi: 10.1101/cshperspect.a001271
38. Kaltschmidt, B., Uherek, M., Volk, B., Baeuerle, P. A., and Kaltschmidt, C. (1997). Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 94, 2642-2647. doi: 10.1073/pnas.94.6.2642
39. Kaltschmidt, B., Widera, D., and Kaltschmidt, C. (2005). Signaling via NF-kappaB in the nervous system. Biochim. Biophys. Acta 1745, 287-299. doi: 10.1016/j.bbamcr.2005.05.009
40. Kaltschmidt, C., Kaltschmidt, B., and Baeuerle, P.A. (1993).Brain synapses contain inducible forms ofthe transcription factor NF-kappa B. Mech. Dev. 43,135-147. doi: 10.1016/0925-4773(93)90031-R
41. Kaltschmidt, C., Kaltschmidt, B., and Baeuerle, P. A. (1995). Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons. Proc. Natl. Acad. Sci. U.S.A. 92, 9618-9622. doi: 10.1073/pnas.92.21.9618
42. Kaltschmidt, C., Kaltschmidt, B., Neumann, H., Wekerle, H., and Baeuerle, P. A. (1994). Constitutive NF-kappa B activity in neurons. Mol. Cell. Biol. 14, 3981-3992. doi: 10.1128/MCB.14.6.3981
43. Khorooshi, R., Babcock, A. A., and Owens, T. (2008). NF-kappaB-driven STAT2 and CCL2 expression in astrocytes in response to brain injury. J. Immunol. 181, 7284-7291. doi: 10.4049/jimmunol.181.10.7284
44. Koo, J. W., Russo, S. J., Ferguson, D., Nestler, E. J., and Duman, R. S. (2010). Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc. Natl. Acad. Sci. U.S.A. 107, 2669-2674. doi: 10.1073/pnas.0910658107
45. Lanzillotta, A., Porrini, V., Bellucci, A., Benarese, M., Branca, C., Parrella, E., et al. (2015). NF-kappaB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases. Front Neurol 6, 98. doi: 10.3389/fneur.2015.00098
46. Lanzillotta, A., Sarnico, I., Ingrassia, R., Boroni, F., Branca, C., Benarese, M., et al. (2010). The acetylation of RelA in Lys310 dictates the NF-kappaB-dependent response in post-ischemic injury. Cell Death Dis 1, e96. doi: 10.1038/cddis.2010.76
47. Ledoux, A. C., and Perkins, N. D. (2014). NF-kappaB and the cell cycle. Biochem. Soc. Trans. 42, 76-81. doi: 10.1042/BST20130156
48. Levenson, J. M., Choi, S., Lee, S. Y., Cao, Y. A., Ahn, H. J., Worley, K. C., et al. (2004). A bioinformatics analysis of memory consolidation reveals involvement of the transcription factor c-rel. J. Neurosci. 24, 3933-3943. doi: 10.1523/JNEUROSCI.5646-03.2004
49. Li, Q., and Verma, I. M. (2002). NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2, 725-734. doi: 10.1038/nri910
50. Li, Z., and Nabel, G. J. (1997). A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription. Mol. Cell. Biol. 17, 6184-6190. doi: 10.1128/MCB.17.10.6184
51. Lilienbaum, A., and Israel, A. (2003). From calcium to NF-kappa B signaling pathways in neurons. Mol. Cell. Biol. 23, 2680-2698. doi: 10.1128/MCB.23.8.2680-2698.2003
52. Lin, C. C., Hsieh, H. L., Shih, R. H., Chi, P. L., Cheng, S. E., andYang, C. M. (2013). Up-regulation of COX-2/PGE2 by endothelin-1 via MAPK-dependent NF-kappaB pathway in mouse brain microvascular endothelial cells. Cell Commun Signal 11, 8. doi: 10.1186/1478-811X-11-8
53. Lin, W. W., and Karin, M. (2007). A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 117, 1175-1183. doi: 10.1172/JCI31537
54. Lukiw, W. J., and Bazan, N. G. (1998). Strong nuclear factor-kappaB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex. J. Neurosci. Res. 53, 583-592. doi: 10.1002/(SICI)1097-4547(19980901)53:5<583::AID-JNR8>3.0.C0;2-5
55. Mattson, M. P. (2005). NF-kappaB in the survival and plasticity of neurons. Neurochem. Res. 30, 883-893. doi: 10.1007/s11064-005-6961-x
56. Meberg, P. J., Kinney, W. R., Valcourt, E. G., and Routtenberg, A. (1996). Gene expression of the transcription factor NF-kappa B in hippocampus: regulation by synaptic activity. Brain Res. Mol. Brain Res. 38, 179-190. doi: 10.1016/0169-328X(95)00229-L
57. Meffert, M. K., and Baltimore, D. (2005). Physiological functions for brain NF-kappaB. Trends Neurosci 28, 37-43. doi: 10.1016/j.tins.2004.11.002
58. Meffert, M. K., Chang, J. M., Wiltgen, B. J., Fanselow, M. S., and Baltimore, D. (2003). NF-kappa B functions in synaptic signaling and behavior. Nat. Neurosci. 6, 1072-1078. doi: 10.1038/nn1110
59. Mercurio, F., Zhu, H., Murray, B. W., Shevchenko, A., Bennett, B. L., Li, J., et al. (1997). IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278, 860-866. doi: 10.1126/science.278.5339.860
60. Niederberger, E., Schmidtko, A., Gao, W., Kuhlein, H., Ehnert, C., and Geisslinger, G. (2007). Impaired acute and inflammatory nociception in mice lacking the p50 subunit of NF-kappaB. Eur. J. Pharmacol 559, 55-60. doi: 10.1016/j.ejphar.2006.11.074
61. Niranjan, R. (2013). Molecular basis of etiological implications in Alzheimer's disease: focus on neuroinflammation. Mol. Neurobiol. 48, 412-428. doi: 10.1007/s12035-013-8428-4
62. Noort, A. R., Tak, P. P., and Tas, S. W. (2015). Noncanonical NF-kappaB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde? Arthritis Res. Ther. 17:15. doi: 10.1186/s13075-015-0527-3
63. O'Neill, L. A., and Kaltschmidt, C. (1997). NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends in neurosciences 20, 252-258. doi: 10.1016/S0166-2236(96)01035-1
64. O'Riordan, K. J., Huang, I. C., Pizzi, M., Spano, P., Boroni, F., Egli, R., et al. (2006). Regulation of nuclear factor kappaB in the hippocampus by group I metabotropic glutamate receptors. J. Neurosci. 26, 4870-4879. doi: 10.1523/JNEUROSCI.4527-05.2006
65. Pan, W., Yu, C., Hsuchou, H., and Kastin, A. J. (2010). The role of cerebral vascular NFkappaB in LPS-induced inflammation: differential regulation of efflux transporter and transporting cytokine receptors. Cell Physiol. Biochem 25, 623-630.
66. Pizzi, M., Boroni, F., Bianchetti, A., Moraitis, C., Sarnico, I., Benarese, M., et al. (2002). Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line. Eur. J. Neurosci. 16, 2342-2350. doi: 10.1046/j.1460-9568.2002.02403.x
67. Pizzi, M., Sarnico, I., Boroni, F., Benarese, M., Steimberg, N., Mazzoleni, G., et al. (2005a). NF-kappaB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid beta-peptide toxicity. Cell Death. Differ 12, 761-772. doi: 10.1038/sj.cdd.4401598
68. Pizzi, M., Sarnico, I., Boroni, F., Benetti, A., Benarese, M., and Spano, P. F. (2005b). Inhibition of IkappaBalpha phosphorylation prevents glutamate-induced NF-kappaB activation and neuronal cell death. Acta Neurochir. Suppl. 93, 59-63. doi: 10.1007/3-211-27577-08
69. Pizzi, M., Sarnico, I., Lanzillotta, A., Battistin, L., and Spano, P. (2009). Post-ischemic brain damage: NF-kappaB dimer heterogeneity as a molecular determinant of neuron vulnerability. FEBS J. 276, 27-35. doi: 10.1111/j.1742-4658.2008.06767.x
70. Regnier, C. H., Song, H. Y., Gao, X., Goeddel, D. V., Cao, Z., and Rothe, M. (1997). Identification and characterization of an IkappaB kinase. Cell 90, 373-383. doi: 10.1016/S0092-8674(00)80344-X
71. Rolls, A., Shechter, R., London, A., Ziv, Y., Ronen, A., et al. (2007). Toll-like receptors modulate adult hippocampal neurogenesis. Nat. Cell Biol. 9, 1081-1088. doi: 10.1038/ncb1629
72. Sarnico, I., Lanzillotta, A., Benarese, M., Alghisi, M., Baiguera, C., Battistin, L., et al. (2009a). NF-kappaB dimers in the regulation of neuronal survival. Int. Rev. Neurobiol. 85, 351-362. doi: 10.1016/S0074-7742(09)85024-1
73. Sarnico, I., Lanzillotta, A., Boroni, F., Benarese, M., Alghisi, M., Schwaninger, M., et al. (2009b). NF-kappaB p50/RelA and c-Rel-containing dimers: opposite regulators of neuron vulnerability to ischaemia. J. Neurochem. 108, 475-485. doi: 10.1111/j.1471-4159.2008.05783.x
74. Schmidt-Ullrich, R., Memet, S., Lilienbaum, A., Feuillard, J., Raphael, M., and Israel, A. (1996). NF-kappaB activity in transgenic mice: developmental regulation and tissue specificity. Development 122, 2117-2128. doi: 10.1101/cshperspect.a001271
75. Schmitz, M. L., and Baeuerle, P. A. (1991). The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO J. 10, 3805-3817. doi: 10.1101/cshperspect.a001271
76. Schneider, A., Martin-Villalba, A., Weih, F., Vogel, J., Wirth, T., and Schwaninger, M. (1999). NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 5, 554-559. doi: 10.1038/6458
77. Schultz, C., Konig, H. G., Del Turco, D., Politi, C., Eckert, G. P., Ghebremedhin, E., et al. (2006).Coincident enrichment of phosphorylated IkappaBalpha, activated IKK, and phosphorylated p65 in the axon initial segment of neurons. Mol. Cell. Neurosci. 33, 68-80. doi: 10.1016/j.mcn.2006.06.008
78. Sen, R., andBaltimore, D. (1986).Inducibilityofkappa immunoglobulin enhancer-binding proteinNf-kappa B byaposttranslational mechanism. Cell 47, 921-928. doi: 10.1016/0092-8674(86)90807-X
79. Shih, R. H., and Yang, C. M. (2010). Induction of heme oxygenase-1 attenuates lipopolysaccharide-induced cyclooxygenase-2 expression in mouse brain endothelial cells. J Neuroinflammation 7, 86. doi: 10.1186/1742-2094-7-86
80. Stone, K. P., Kastin, A. J., and Pan, W. (2011). NFkB is an unexpected major mediator of interleukin-15 signaling in cerebral endothelia. Cell Physiol. Biochem 28, 115-124. doi: 10.1159/000331720
81. Sun, S. C. (2012). The noncanonical NF-kappaB pathway. Immunol. Rev. 246, 125-140. doi: 10.1111/j.1600-065X.2011.01088.x
82. Tak, P. P., Gerlag, D. M., Aupperle, K. R., Van De Geest, D. A., Overbeek, M., Bennett, B. L., et al. (2001). Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation. Arthritis Rheum. 44, 1897-1907. doi: 10.1002/1529-0131(200108)44:8<1897::AID-ART328>3.0.C0;2-4
83. Thanos, D., and Maniatis, T. (1995). NF-kappa B: a lesson in family values. Cell 80, 529-532. doi: 10.1016/0092-8674(95)90506-5
84. Tilstra, J. S., Robinson, A. R., Wang, J., Gregg, S. Q., Clauson, C. L., Reay, D. P., et al. (2012). NF-kappaB inhibition delays DNA damage-induced senescence and aging in mice. J. Clin. Invest. 122, 2601-2612. doi: 10.1172/JCI45785
85. Tsai, C. L., Chen, W. C., Hsieh, H. L., Chi, P. L., Hsiao, L. D., and Yang, C. M. (2014). TNF-alpha induces matrix metalloproteinase-9-dependent soluble intercellular adhesion molecule-1 release via TRAF2-mediated MAPKs and NF-kappaB activation in osteoblast-like MC3T3-E1 cells. J. Biomed. Sci. 21, 12. doi: 10.1186/1423-0127-21-12
86. Valerio, A., Boroni, F., Benarese, M., Sarnico, I., Ghisi, V., Bresciani, L. G., et al. (2006). NF-kappaB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production. Eur. J. Neurosci. 23, 1711-1720. doi: 10.1111/j.1460-9568.2006.04722.x
87. Valerio, A., Dossena, M., Bertolotti, P., Boroni, F., Sarnico, I., Faraco, G., et al. (2009). Leptin is induced in the ischemic cerebral cortex and exerts neuroprotection through NF-kappaB/c-Rel-dependent transcription. Stroke 40, 610-617. doi: 10.1161/STROKEAHA.108.528588
88. Vallabhapurapu, S., and Karin, M. (2009). Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 27, 693-733. doi: 10.1146/annurev.immunol.021908.132641
89. Verma, I. M., Stevenson, J. K., Schwarz, E. M., Van Antwerp, D., and Miyamoto, S. (1995). Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev. 9, 2723-2735. doi: 10.1101/gad.9.22.2723
90. Wellmann, H., Kaltschmidt, B., and Kaltschmidt, C. (2001). Retrograde transport of transcription factor NF-kappa B in living neurons. J. Biol. Chem. 276, 11821-11829. doi: 10.1074/jbc.M009253200
91. Whiteside, S. T., Epinat, J. C., Rice, N. R., and Israel, A. (1997). I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity. EMBO J. 16, 1413-1426. doi: 10.1093/emboj/16.6.1413
92. Yakovleva, T., Bazov, I., Watanabe, H., Hauser, K. F., and Bakalkin, G. (2011). Transcriptional control ofmaladaptive and protective responses in alcoholics: a role ofthe NF-kappaB system. Brain Behav. Immun. 25(Suppl. 1), S29-S38. doi: 10.1016/j.bbi.2010.12.019
93. Yamamoto, Y., Verma, U. N., Prajapati, S., Kwak, Y. T., and Gaynor, R. B. (2003). Histone H3 phosphorylation byIKK-alpha is critical for cytokine-induced gene expression. Nature 423, 655-659. doi: 10.1038/nature01576
94. Yang, C. M., Chien, C. S., Hsiao, L. D., Luo, S. F., and Wang, C. C. (2002). Interleukin-1beta-induced cyclooxygenase-2 expression is mediated through activation of p42/44 and p38. MAPKS, and NF-kappaB pathways in canine tracheal smooth muscle cells. Cell. Signal. 14, 899-911. doi: 10.1016/S0898-6568(02)00037-2
95. Yang, C. M., Luo, S. F., Hsieh, H. L., Chi, P. L., Lin, C. C., Wu, C. C., et al. (2010). Interleukin-1beta induces ICAM-1 expression enhancing leukocyte adhesion in human rheumatoid arthritis synovial fibroblasts: involvement of ERK, JNK, AP-1, and NF-kappaB. J. Cell. Physiol. 224, 516-526. doi: 10.1002/jcp.22153
96. Zandi, E., Rothwarf, D. M., Delhase, M., Hayakawa, M., and Karin, M. (1997). The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell91, 243-252. doi: 10.1016/S0092-8674(00)80406-7
97. Zhang, G., Li, J., Purkayastha, S., Tang, Y., Zhang, H., Yin, Y., et al. (2013). Hypothalamic programming of systemic ageing involving IKK-beta, NF-kappaB and GnRH. Nature 497, 211-216. doi: 10.1038/nature12143
98. Zhang, H., Hilton, M. J., Anolik, J. H., Welle, S. L., Zhao, C., Yao, Z., et al. (2014). NOTCH inhibits osteoblast formation in inflammatory arthritis via noncanonical NF-kappaB. J. Clin. Invest. 124, 3200-3214. doi: 10.1038/nri910